MULTICENTER PROSPECTIVE STUDY FOR THE USE OF SHORTENED PREEMPTIVE THERAPY WITH GLECAPREVIR/PIBRENTASVIR (G/P) AND EZETIMIBE IN HEPATITIS C SERONEGATIVE NON-LIVER SOLID ORGAN TRANSPLANT (TX) RECIPIENTS OF HEPATITIS C (HCV) VIREMIC DONORS

被引：0
|
作者：
Aqel, Bashar A. [1 ,2 ]
Pungpapong, Surakit [3 ]
Moss, Adyr [1 ]
Ryland, Kristen [4 ]
Dickson, Rolland [2 ]
机构：
[1] Mayo Clin Arizona, Phoenix, AZ USA
[2] Mayo Clin Arizona, Gastroenterol & Hepatol, Phoenix, AZ USA
[3] Mayo Clin Florida, Transplantat, Jacksonville, FL USA
[4] Mayo Clin Florida, Jacksonville, FL USA
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
976
引用
收藏
页码：597A / 597A
页数：1
相关论文
共 9 条
  • [1] Multicenter prospective study for the use of shortened pre-emptive therapy with Glecaprevir/Pibrentasvir (G/P) and Ezetimibe in hepatitis C (HCV) seronegative non-liver solid organ transplant recipients of HCV viremic grafts
    Aqel, Bashar
    Pungpapong, Surakit
    Moss, Adyr
    Dickson, Rolland
    JOURNAL OF HEPATOLOGY, 2022, 77 : S15 - S16
  • [2] Pilot Study for the Use of Shortened Preemptive Therapy with Glecaprevir/pibrentasvir (g/p) and Ezetimibe in Hepatitis C Seronegative Solid Organ Transplant Recipients (Kidney and Heart) of Hepatitis C Viremic Donors
    Aqel, B.
    Khamash, H.
    Moss, A.
    Steidley, D. E.
    Dickson, R. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 489 - 490
  • [3] PILOT STUDY FOR THE USE OF SHORTENED PREEMPTIVE THERAPY WITH GLECAPREVIR/PIBRENTASVIR AND EZETIMIBE IN HEPATITIS C SERONEGATIVE SOLID ORGAN TRANSPLANT RECIPIENTS (KIDNEY/HEART) OF HEPATITIS C VIREMIC DONORS
    Aqel, Bashar
    Moss, Adyr A.
    Dickson, Rolland
    GASTROENTEROLOGY, 2021, 160 (06) : S776 - S776
  • [4] OUTCOMES OF NON-LIVER SOLID ORGAN TRANSPLANTATION USING HEPATITIS C POSITIVE DONORS TO HEPATITIS C NEGATIVE RECIPIENTS: A MULTICENTER EXPERIENCE
    Ryland, Kristen
    Aqel, Bashar
    Mallea, Jorge
    Mao, Shennen
    Erasmus, David
    Patel, Parag
    Si Pham
    Steidley, David E.
    Huskey, Janna
    Moss, Adyr
    Pungpapong, Surakit
    TRANSPLANTATION, 2020, 104 (09) : S108 - S109
  • [5] GLECAPREVIR/PIBRENTASVIR (G/P) AND EZETIMIBE FOR 8 DAYS SHOULD BE THE NEW STANDARD OF CARE WITH 100% EFFICACY TO PREVENT CHRONIC HCV INFECTION IN NON-LIVER SOLID ORGAN TRANSPLANT (SOT) RECIPIENTS OF HCV-VIREMIC GRAFTS
    Aqel, Bashar A.
    Pungpapong, Surakit
    Ryland, Kristen
    Moss, Adyr
    Leise, Michael D.
    Dickson, Rolland
    HEPATOLOGY, 2022, 76 : S354 - S355
  • [6] ULTRA-SHORT COURSE GLECAPREVIR/PIBRENTASVIR WITH EZETIMIBE IN THE PREVENTION OF HEPATITIS C (HCV) TRANSMISSION FROM HCV-POSITIVE ORGAN DONORS TO HCV-NEGATIVE RECIPIENTS: ONGOING EXPERIENCE
    Aleyadeh, Wesam
    Bahinskaya, Ilona
    Cypel, Marcelo
    Humar, Atul
    Feld, Jordan J.
    HEPATOLOGY, 2022, 76 : S405 - S406
  • [7] Prospective multicenter study of sofosbuvir-velpatasvir (SOF/VEL) in hepatitis C virus (HCV) negative liver (LT) and kidney transplant (KT) recipients receiving HCV viremic donors
    Rubin, Raymond
    Victor, David
    Burton, James
    Verna, Elizabeth
    Trotter, James F.
    Niemann, Claus
    Mobley, Constance
    Terrault, Norah
    JOURNAL OF HEPATOLOGY, 2020, 73 : S276 - S276
  • [8] Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection
    Sise, Meghan E.
    Goldberg, David S.
    Kort, Jens J.
    Schaubel, Douglas E.
    Alloway, Rita R.
    Durand, Christine M.
    Fontana, Robert J.
    Brown, Robert S., Jr.
    Friedewald, John J.
    Prenner, Stacey
    Landis, J. Richard
    Fernando, Melissa
    Phillips, Caitlin C.
    Woodle, E. Steve
    Rike-Shields, Adele
    Sherman, Kenneth E.
    Elias, Nahel
    Williams, Winfred W.
    Gustafson, Jenna L.
    Desai, Niraj M.
    Barnaba, Brittany
    Norman, Silas P.
    Doshi, Mona
    Sultan, Samuel T.
    Aull, Meredith J.
    Levitsky, Josh
    Belshe, Dianne S.
    Chung, Raymond T.
    Reese, Peter P.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (11): : 2678 - 2687
  • [9] Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: A preliminary report from a prospective randomized study
    Kato, T
    Yoshida, H
    Sadfar, K
    Martinez, E
    Nishida, S
    Moon, J
    Madariaga, J
    Selvaggi, G
    Levi, D
    Ruiz, P
    Schiff, E
    Tzakis, A
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 1217 - 1219
1